Martner lab (@Martnerlab) header
Martner lab (@Martnerlab) profile picture

Immunotherapy, NOX2, MDSC

SCCR, Gothenburg, Sweden
Joined August 2013
Photo by Martner lab (@Martnerlab)Photo by Martner lab (@Martnerlab)Photo by Martner lab (@Martnerlab)Photo by Martner lab (@Martnerlab)Photo by Martner lab (@Martnerlab)Photo by Martner lab (@Martnerlab)Photo by Martner lab (@Martnerlab)
Martner lab retweeted
Priset för Sahlgrenska Life kan bli att nästa generation forskare drabbas av en hyresnota som begränsar deras möjlighet att bedriva framgångsrik forskning, skriver 23 representanter från Sahlgrenska akademien i ett gemensamt upprop.gp.se/debatt/l%C3%A5t-inte-s…
6
14
It is finally online! This work and others point to treating with #IFNs early in #COVID19, here #IFNL! Such hard work by @JJFeld & many others to get this 1st trial done. Lots still left to do immunology wise as part of our #CIHR grant! Free access here authors.elsevier.com/c/1cXZW…
5
13
2
53
So, here is our data comparing immune responses in people who had a SARS-CoV-2 infection and were then vaccinated once and people who were naive and then were vaccinated once. I'll explain this a little better tonight if I find time. medrxiv.org/content/10.1101/…
88
494
196
1,747
Martner lab retweeted
Crispr!
BREAKING NEWS: The 2020 #NobelPrize in Chemistry has been awarded to Emmanuelle Charpentier and Jennifer A. Doudna “for the development of a method for genome editing.”
BREAKING NEWS: The 2020 #NobelPrize in Physiology or Medicine has been awarded jointly to Harvey J. Alter, Michael Houghton and Charles M. Rice “for the discovery of Hepatitis C virus.”
409
14,914
2,533
30,071
IL-2 immunotherapy expands tumor-infiltrating DCs through a lymphoid pathway, favoring the conversion of poorly immunogenic into immunogenic tumors. stm.sciencemag.org/content/1…
2
2
Martner lab retweeted
My first tweet😃, The paper is out, great team work, thank you all! exciting! nature.com/articles/s41590-0…
7
44
5
154
This reinfected patient got worse the 2nd time. No info on antibodies or T cells. As an immunologist this is bad news. I suggest vaccine strategies to evoke multi-specific T cells and antibodies are developed as single epitope approaches are likely to fail.
A 25 yr old patient in Nevada has a confirmed case of #COVID19 reinfection (48 days apart between 1st and 2nd PCR). This time, unlike the case in Hong Kong, the immune system did not protect this person from reinfection or disease. (1/n) papers.ssrn.com/sol3/papers.…